Anthony Cerami
Affiliations: | Rockefeller University, New York, NY, United States |
Google:
"Anthony Cerami"Parents
Sign in to add mentor| Edward Reich | grad student | 1962-1967 | Rockefeller Institute for Medical Research (Chemistry Tree) |
Children
Sign in to add trainee| Nina F. Schor | grad student | 1977-1980 | Rockefeller (Neurotree) |
| Peter Hotez | grad student | 1985 | Rockefeller (ID Tree) |
| Bruce Alan Beutler | post-doc | Rockefeller |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Nairz M, Haschka D, Dichtl S, et al. (2017) Cibinetide dampens innate immune cell functions thus ameliorating the course of experimental colitis. Scientific Reports. 7: 13012 |
| Collino M, Thiemermann C, Cerami A, et al. (2015) Flipping the molecular switch for innate protection and repair of tissues: Long-lasting effects of a non-erythropoietic small peptide engineered from erythropoietin. Pharmacology & Therapeutics. 151: 32-40 |
| Ueba H, Shiomi M, Brines M, et al. (2013) Suppression of coronary atherosclerosis by helix B surface Peptide, a nonerythropoietic, tissue-protective compound derived from erythropoietin. Molecular Medicine (Cambridge, Mass.). 19: 195-202 |
| Beutler B, Milsark IW, Cerami AC. (2008) Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science, 1985, 229(4716):869-871. Classical article. Journal of Immunology (Baltimore, Md. : 1950). 181: 7-9 |
| Taoufik E, Petit E, Divoux D, et al. (2008) TNF receptor I sensitizes neurons to erythropoietin- and VEGF-mediated neuroprotection after ischemic and excitotoxic injury. Proceedings of the National Academy of Sciences of the United States of America. 105: 6185-90 |
| Brines M, Cerami A. (2006) Discovering erythropoietin's extra-hematopoietic functions: biology and clinical promise. Kidney International. 70: 246-50 |
| Savino C, Pedotti R, Baggi F, et al. (2006) Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis. Journal of Neuroimmunology. 172: 27-37 |
| Ghezzi P, Cerami A. (2005) Tumor necrosis factor as a pharmacological target. Molecular Biotechnology. 31: 239-44 |
| Beutler B, Cerami A. (2005) Cachectin--Tumour necrosis factor: a cytokine that mediates injury initiated by invasive parasites. Parasitology Today (Personal Ed.). 3: 345-6 |
| Brines M, Grasso G, Fiordaliso F, et al. (2004) Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor. Proceedings of the National Academy of Sciences of the United States of America. 101: 14907-12 |